Standard BioTools Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Standard BioTools Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $78.00K.
- Standard BioTools Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $68.00K, a 20.93% decline year-over-year.
- Standard BioTools Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $981.00K.
- Standard BioTools Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $72.00K.
- Standard BioTools Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $531.00K, a 53.91% decline from fiscal 2024.
- Standard BioTools Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $1.15M, a 1322.22% increase from fiscal 2023.
- Standard BioTools Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $81.00K, a 17.35% decline from fiscal 2022.
- Standard BioTools Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $98.00K, a 53.11% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $78.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $531.00K 10-K · filed 2026-03-16 | |
| 2024-12-31 | $1.15M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $68.00K 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $981.00K 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $72.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $81.00K 10-K · filed 2026-03-16 | |
| 2023-09-30 | $86.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $98.00K 10-K · filed 2025-03-11 | |
| 2022-06-30 | $96.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $2.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $209.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | -$1.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $209.00K 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $451.00K 10-K · filed 2022-03-08 | |
| 2020-09-30 | $450.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $1.06M 10-K · filed 2022-03-08 | |
| 2019-09-30 | $1.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $793.00K 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $255.00K 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $208.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | $13.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $7.00K 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $72.00K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $100.00K 10-K · filed 2020-02-27 | |
| 2016-12-31 | $227.00K 10-K · filed 2019-03-18 | |
| 2015-12-31 | $5.30M 10-K · filed 2018-03-08 | |
| 2014-12-31 | $5.11M 10-K · filed 2017-03-03 | |
| 2013-12-31 | $5.81M 10-K · filed 2016-02-29 | |
| 2012-12-31 | $2.70M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |